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• Residence Time(τm) – The time that a given water molecule 
spends in direct interaction with the Gd(III) ion. 
 
• Tumbling Rate(τR) – Describes period of the molecular Brownian 
motion for the Gd chelate. 
 
• q – The average number of water molecules directly interacting 
with Gd at any given time. 
 
• Secondary Sphere Interaction – The interaction with water 
molecules not directly bound to the Gd center, but oriented in an 
organized fashion relative to the chelate.  
 Magnetic resonance imaging (MRI) is an important 
technique used throughout the medical field to gain improved 
clinical diagnostic ability.  Often, different tissues can be 
weighted within the images if MRI contrast agents are used.  
Common clinical contrast agents use gadolinium to alter the T1 
relaxation times of protons within surrounding tissues.  
Gadolinium(III), a lanthanide cation, has a grand seven unpaired 
electrons with its electronic configuration [Xe] 4f7.  There are 
already a plethora of gadolinium chelate contrast agents 
available for medical use and for research. However the 
sensitivity of these agents may be improved by increasing the 
rotational correlation time, τr. The goal of slower tumbling rates 
can be achieved by increasing their molecular weight.  Thus, we 
propose attaching multiple gadolinium chelates to a central 
transition metal scaffold.  The increase in molecular weight will 
alter the τr and improve the relaxation efficiency of the agent.  
These metal scaffolds will most likely include a Ru3O core. 
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Advantages Disadvantages 
• Provides differentiation 
between tissues 
• Improves MRI sensitivity 
and contrast 
• Limited contrast 
efficiency 
• Lack of multi-modal 
capability 
Clinical MRI Contrast Agents 





• Longer relaxation time achieved by 
Meade et al. with a multiplexed 
probe with three separate 
gadolinium chelates attached to a 
core scaffold via click chemistry.  
Observed τr of 0.74 ns compared 
to 0.067 ns for the lone chelate at 
298 K.1   
 
• Metallostars with six Gd(III) centers 
successfully used for in vivo tests 
in mice by Livramento et al.  The 
metallostar contrast agent proved 
useful for high-field applications 
(9.4 T).  Results were compared to 
a commercial agent, GdDOTA; this 
comparison showed improved 
relaxivity of up to four times the 
commercial agent with an external 
4.7 T field.2 
 The desired ligand 4-(DO3A)MePy was synthesized via the functionalization of cyclen to 
tBuDO3A, which was further functionalized to 4-(tBuDO3A)MePy.  The ligand was then 
deprotected with TFA.  Finally, GdCl3 was used to facilitate the coordination to the complex.  
Procedures were derived from the literature describing syntheses of similar chelates.3, 4  This 
ligand is ideal for a number of reasons, including that it does not allow for the discharge of free 
Gd(III), which is toxic, and it is potentially capable of attaching to a transition metal scaffold 
core, allowing for multiple chelates to act in unison. 
 Each compound was primarily characterized by ESI mass 
spectrometry, along with NMR spectroscopy.  The final predicted 
isotopic envelope of the gadolinium chelate is presented.  The 
peaks and intensities matched up with the experimentally 
observed isotopic envelope.  The predicted and experimental 
isotopic envelopes were thus in good agreement, providing 
evidence for the synthesis of the chelate. 
 The pyridine arm on the ligand should allow for multiple 
chelates to be attached to a ruthenium oxide scaffold.  The 
resultant macromolecule should have a slow tumbling rate.  The 
reduction in the tumbling rate should give rise to a longer 
rotational correlation time τr, which should increase the T1 
relaxation time for protons in water molecules.   
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i – t-butyl bromoacetate, 
sodium acetate, DMA 
 







iii – TFA, DCM 
 
iv – GdCl3, pH 6.5 
Theranostic Contrast Agents 
• There is a growing need to visualize the efficacy of treatment 
in many areas of medicine. 
• A theranostic agent combines a delivered therapeutic agent 
with a diagnostic agent. 
• Theranostics enable visualization of drug localization and 
facilitate the development of tailored treatment plans. 
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